Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).

Modification with SUMO. A role in transcriptional regulation. EMBO Rep (2003) 3.25

PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol Cell Biol (2002) 3.25

SUMOylation and De-SUMOylation: wrestling with life's processes. J Biol Chem (2008) 3.22

Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci U S A (2002) 2.85

Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. EMBO J (2002) 2.77

SUMO-targeted ubiquitin ligases in genome stability. EMBO J (2007) 2.77

The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J (2002) 2.56

Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J (2002) 2.41

Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1. Mol Cell Biol (2003) 2.17

Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat Rev Neurosci (2007) 1.97

Role of desumoylation in the development of prostate cancer. Neoplasia (2006) 1.90

SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol (2004) 1.89

A domain unique to plant RanGAP is responsible for its targeting to the plant nuclear rim. Proc Natl Acad Sci U S A (2001) 1.72

Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase. J Biol Chem (2011) 1.60

Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc Natl Acad Sci U S A (2003) 1.60

Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc Natl Acad Sci U S A (2003) 1.52

Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol Cell Biol (2002) 1.48

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal (2008) 1.47

Targets and consequences of protein SUMOylation in neurons. Brain Res Rev (2010) 1.44

The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification. Mol Cell Biol (2005) 1.43

The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium. Endocrinology (2008) 1.42

Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc Natl Acad Sci U S A (2007) 1.41

SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5. Proc Natl Acad Sci U S A (2007) 1.39

Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochem J (2002) 1.33

Role for SUMO modification in facilitating transcriptional repression by BKLF. Mol Cell Biol (2005) 1.31

hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. EMBO J (2003) 1.28

Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. Pigment Cell Res (2005) 1.28

Androgen receptor signaling and mutations in prostate cancer. Asian J Androl (2010) 1.27

Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochem J (2005) 1.27

Negative modulation of androgen receptor transcriptional activity by Daxx. Mol Cell Biol (2004) 1.26

Post-translational modifications of nuclear receptors and human disease. Nucl Recept Signal (2012) 1.23

Arabidopsis nitrate reductase activity is stimulated by the E3 SUMO ligase AtSIZ1. Nat Commun (2011) 1.21

The small ubiquitin-like modifier (SUMO) is required for gonadal and uterine-vulval morphogenesis in Caenorhabditis elegans. Genes Dev (2004) 1.20

Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation. J Biol Chem (2009) 1.19

Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer. Proc Natl Acad Sci U S A (2009) 1.17

Posttranslational modification of the androgen receptor in prostate cancer. Int J Mol Sci (2013) 1.16

SUMOylation attenuates the function of PGC-1alpha. J Biol Chem (2009) 1.14

SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX. Mol Endocrinol (2008) 1.12

Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification. Proc Natl Acad Sci U S A (2001) 1.11

Supervillin associates with androgen receptor and modulates its transcriptional activity. Proc Natl Acad Sci U S A (2002) 1.10

Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity. BMC Biochem (2006) 1.10

Functional role of NF-IL6beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene. Nucleic Acids Res (2006) 1.08

Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease. Neuroscientist (2011) 1.08

Nuclear receptor coactivators: structural and functional biochemistry. Biochemistry (2010) 1.06

PPARs and lipid ligands in inflammation and metabolism. Chem Rev (2011) 1.06

Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation. Oncogene (2011) 1.05

Dynamic SUMOylation is linked to the activity cycles of androgen receptor in the cell nucleus. Mol Cell Biol (2012) 1.04

SUMO-1 modification of human cytomegalovirus IE1/IE72. J Virol (2002) 1.03

Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction. Physiol Rev (2014) 1.02

The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover. Nucleic Acids Res (2013) 1.00

Repression of PML nuclear body-associated transcription by oxidative stress-activated Bach2. Mol Cell Biol (2004) 0.99

Phosphorylation of androgen receptor isoforms. Biochem J (2004) 0.98

Conjugation of Smt3 to dorsal may potentiate the Drosophila immune response. Mol Cell Biol (2002) 0.98

Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease. J Clin Invest (2015) 0.98

Androgen receptor abnormalities in castration-recurrent prostate cancer. Expert Rev Endocrinol Metab (2009) 0.97

Oncogenic activation of androgen receptor. Urol Oncol (2008) 0.97

Protein SUMOylation in neuropathological conditions. Drug News Perspect (2009) 0.97

The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs. J Biol Chem (2012) 0.96

Structural and functional analysis of domains of the progesterone receptor. Mol Cell Endocrinol (2011) 0.95

The serine/arginine-rich protein SF2/ASF regulates protein sumoylation. Proc Natl Acad Sci U S A (2010) 0.95

SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR. J Biol Chem (2009) 0.94

Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation. BMC Mol Biol (2012) 0.94

Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription. EMBO J (2006) 0.94

Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription. Endocrinology (2011) 0.92

Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation. Nucleic Acids Res (2007) 0.92

Ligand binding domain mutations of the glucocorticoid receptor selectively modify the effects with, but not binding of, cofactors. Biochemistry (2010) 0.91

Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcription. Mol Biol Cell (2002) 0.91

Post-translational modifications of the progesterone receptors. J Steroid Biochem Mol Biol (2013) 0.88

GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression. Proc Natl Acad Sci U S A (2015) 0.87

Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation. J Biol Chem (2009) 0.87

Role of nuclear receptors in blastocyst implantation. Semin Cell Dev Biol (2013) 0.87

Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2. J Biol Chem (2012) 0.86

RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity. Mol Cell Biol (2013) 0.86

SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner. Nucleic Acids Res (2014) 0.86

Androgen receptor serine 81 mediates Pin1 interaction and activity. Cell Cycle (2012) 0.84

General molecular biology and architecture of nuclear receptors. Curr Top Med Chem (2012) 0.84

Differential regulation of the two transcriptional activation domains of the coiled-coil coactivator CoCoA by sumoylation. BMC Mol Biol (2008) 0.84

Identifications of SUMO-1 cDNA and its expression patterns in Pacific white shrimp Litopeanaeus vannamei. Int J Biol Sci (2009) 0.83

SUMOylation regulates the nuclear mobility of CREB binding protein and its association with nuclear bodies in live cells. Biochem Biophys Res Commun (2009) 0.83

Identification of estrogen receptor β as a SUMO-1 target reveals a novel phosphorylated sumoylation motif and regulation by glycogen synthase kinase 3β. Mol Cell Biol (2012) 0.83

Dynamic SUMO modification regulates mitotic chromosome assembly and cell cycle progression in Caenorhabditis elegans. Nat Commun (2014) 0.82

NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases. BMC Med Genomics (2013) 0.81

PIASγ enhanced SUMO-2 modification of Nurr1 activation-function-1 domain limits Nurr1 transcriptional synergy. PLoS One (2013) 0.81

Thyroid hormone receptor isoform-specific modification by small ubiquitin-like modifier (SUMO) modulates thyroid hormone-dependent gene regulation. J Biol Chem (2012) 0.81

SUMO modification of NZFP mediates transcriptional repression through TBP binding. Mol Cells (2012) 0.81

Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy. CNS Neurol Disord Drug Targets (2013) 0.80

Differential recruitment of coregulators to the RORA promoter adds another layer of complexity to gene (dys) regulation by sex hormones in autism. Mol Autism (2013) 0.80

Sentrin/SUMO specific proteases as novel tissue-selective modulators of vitamin D receptor-mediated signaling. PLoS One (2014) 0.80

Role of SUMOylation in full antiestrogenicity. Mol Cell Biol (2012) 0.80

New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancer. Prostate Cancer (2011) 0.79

Pathogenic polyglutamine expansion length correlates with polarity of the flanking sequences. Mol Neurodegener (2014) 0.79

PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer. Oncogene (2015) 0.79

Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells. PLoS One (2013) 0.79

SUMOylation of DLX3 by SUMO1 promotes its transcriptional activity. J Cell Biochem (2011) 0.79

Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications. Int J Mol Sci (2015) 0.79

Modulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modifications. Yonsei Med J (2013) 0.77

Identification of androgen receptor phosphorylation in the primate ovary in vivo. Reproduction (2010) 0.77

SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity. PLoS One (2013) 0.77

Identification of c-MYC SUMOylation by mass spectrometry. PLoS One (2014) 0.77

Modification by SUMOylation Controls Both the Transcriptional Activity and the Stability of Delta-Lactoferrin. PLoS One (2015) 0.75

A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell (1997) 9.01

Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev (1999) 7.42

Steroid hormone receptors: many actors in search of a plot. Cell (1995) 7.22

SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell (1998) 6.62

The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J (1991) 6.08

PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83

A new protease required for cell-cycle progression in yeast. Nature (1999) 5.44

SUMO--nonclassical ubiquitin. Annu Rev Cell Dev Biol (2000) 5.37

Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J (1998) 5.15

The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J (1997) 4.80

Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature (1995) 4.20

SUMO-1 modification activates the transcriptional response of p53. EMBO J (1999) 4.19

Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J Biol Chem (1997) 3.76

SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J Cell Biol (1998) 3.65

Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J (1999) 3.08

Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol (1987) 3.08

Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. J Cell Biol (1999) 3.03

Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci U S A (1999) 2.81

c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem (2000) 2.71

Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci U S A (2000) 2.69

SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci (1999) 2.46

A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J Biol Chem (1994) 2.35

Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem (2000) 2.34

Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J Cell Biol (1998) 2.29

The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem (1999) 2.21

Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J Biol Chem (1999) 2.18

Increasing the complexity of coactivation in nuclear receptor signaling. Cell (1999) 2.09

The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc Natl Acad Sci U S A (1998) 2.05

Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem (1995) 2.02

Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem (1997) 1.92

A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol Cell Biol (2000) 1.90

Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J Biol Chem (1997) 1.80

Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J Biol Chem (1999) 1.65

Ligand-independent activation of steroid hormone receptors. J Mol Med (Berl) (1998) 1.63

In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem Biophys Res Commun (1999) 1.61

Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol Cell Biol (1998) 1.60

Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem (1996) 1.60

Nuclear import of the human androgen receptor. Biochem J (1993) 1.58

A new 30-kDa ubiquitin-related SUMO-1 hydrolase from bovine brain. J Biol Chem (1999) 1.38

The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. J Cell Sci (2000) 1.34

Coregulator small nuclear RING finger protein (SNURF) enhances Sp1- and steroid receptor-mediated transcription by different mechanisms. J Biol Chem (2000) 1.20

Interaction of androgen receptors with androgen response element in intact cells. Roles of amino- and carboxyl-terminal regions and the ligand. J Biol Chem (1997) 1.12

1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol Endocrinol (1999) 1.11

Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor. Steroids (1996) 1.01

Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem (1997) 1.92

Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet (2000) 1.87

Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol Endocrinol (2001) 1.71

Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J Biol Chem (1999) 1.65

Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol Cell Biol (1998) 1.60

Novel assay for determination of androgen bioactivity in human serum. J Clin Endocrinol Metab (2001) 1.57

ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol Endocrinol (2000) 1.55

A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J Biol Chem (1999) 1.51

CREB-binding protein in androgen receptor-mediated signaling. Proc Natl Acad Sci U S A (1998) 1.47

Androgen-receptor-interacting nuclear proteins. Biochem Soc Trans (2000) 1.38

Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology (1994) 1.37

The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. J Cell Sci (2000) 1.34

Coregulator small nuclear RING finger protein (SNURF) enhances Sp1- and steroid receptor-mediated transcription by different mechanisms. J Biol Chem (2000) 1.20

A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A (1994) 1.20

Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells. Oncogene (2008) 1.13

Activation of androgen receptor function by a novel nuclear protein kinase. Mol Biol Cell (1998) 1.13

Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity. FEBS Lett (2004) 1.13

Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol Endocrinol (1995) 1.12

Interaction of androgen receptors with androgen response element in intact cells. Roles of amino- and carboxyl-terminal regions and the ligand. J Biol Chem (1997) 1.12

Analysis of androgen receptor-DNA interactions with receptor proteins produced in insect cells. J Biol Chem (1994) 1.03

Disruption of the murine PIASx gene results in reduced testis weight. J Mol Endocrinol (2005) 1.01

Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Mol Endocrinol (2001) 1.00

Transcription activating and repressing functions of the androgen receptor are differentially influenced by mutations in the deoxyribonucleic acid-binding domain. Endocrinology (1999) 0.96

Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes. J Immunol (2000) 0.93

Androgen receptor and mechanism of androgen action. Ann Med (1993) 0.93

Agonists, but not antagonists, alter the conformation of the hormone-binding domain of androgen receptor. Endocrinology (1994) 0.92

Expression of androgen receptor in insect cells. Purification of the receptor and renaturation of its steroid- and DNA-binding functions. J Biol Chem (1992) 0.89

The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells. FEBS Lett (1997) 0.89

Effects of mitogens on androgen receptor-mediated transactivation. Endocrinology (1996) 0.89

FoxA1 corrupts the antiandrogenic effect of bicalutamide but only weakly attenuates the effect of MDV3100 (Enzalutamide™). Mol Cell Endocrinol (2012) 0.88

Heterodimerization is mainly responsible for the dominant negative activity of amino-terminally truncated rat androgen receptor forms. FEBS Lett (1998) 0.87

Characterization of the cystatin B gene promoter harboring the dodecamer repeat expanded in progressive myoclonus epilepsy, EPM1. Gene (2000) 0.87

Comparison of androgen regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organs. Endocrinology (1992) 0.86

A single-base substitution in exon 6 of the androgen receptor gene causing complete androgen insensitivity: the mutated receptor fails to transactivate but binds to DNA in vitro. Hum Mol Genet (1993) 0.84

The RING finger protein SNURF is a bifunctional protein possessing DNA binding activity. J Biol Chem (2001) 0.82

Regulation of the rat p75 neurotrophin receptor promoter by GC element binding proteins. Biochem Biophys Res Commun (1996) 0.82

Functional interference between AP-1 and the vitamin D receptor on osteocalcin gene expression in human osteosarcoma cells. Eur J Biochem (1994) 0.81

Molecular cloning and characterization of the human mitochondrial 2,4-dienoyl-CoA reductase gene (DECR). Genomics (1997) 0.81

Nuclear factor Y activates the human xanthine oxidoreductase gene promoter. FEBS Lett (2000) 0.79

Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei. FEBS Lett (2002) 0.78

Functional analysis of the C(-188)A polymorphism of the human leptin promoter. Hum Genet (1998) 0.77

Structural comparison of human and rat prostate-specific acid phosphatase genes and their promoters: identification of putative androgen response elements. Biochem Biophys Res Commun (1994) 0.77

Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties. Am J Pathol (1996) 0.77

Genetic regulation of androgen action. Prostate Suppl (1996) 0.77

Estrogen receptor in human myoma tissue. Mol Cell Endocrinol (1976) 0.77

Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription. Mol Endocrinol (1997) 0.77

Differential regulation of specific gene expression in mouse kidney by androgens and antiandrogens. Adv Exp Med Biol (1986) 0.76

Androgen receptors and skeletal muscle composition in trotters treated with nandrolone laureate. Zentralbl Veterinarmed A (1997) 0.76

Localization of xanthine dehydrogenase mRNA in horse skeletal muscle by in situ hybridization with digoxigenin-labelled probe. Biochem J (1993) 0.75

Production of recombinant androgen receptor in a heterologous expression system. Clin Chem (1993) 0.75

Analysis of baculovirus-expressed androgen receptors. Ann N Y Acad Sci (1993) 0.75